NewEdge Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Buy
876,466
+46,804
+6% +$1.18M 0.07% 269
2026
Q1
$21M Sell
829,662
-30,551
-4% -$779K 0.08% 250
2025
Q4
$22M Buy
860,213
+28,474
+3% +$729K 0.08% 224
2025
Q3
$21.4M Buy
831,739
+705,793
+560% +$17.9M 0.1% 215
2025
Q2
$3.18M Sell
125,946
-41,870
-25% -$1.04M 0.02% 740
2025
Q1
$4.19M Buy
167,816
+132,506
+375% +$3.28M 0.02% 568
2024
Q4
$868K Sell
35,310
-43,121
-55% -$1.08M 0.01% 1236
2024
Q3
$2.02M Sell
78,431
-456,910
-85% -$11.5M 0.01% 797
2024
Q2
$13.1M Sell
535,341
-345,817
-39% -$8.45M 0.1% 212
2024
Q1
$21.2M Buy
881,158
+413,503
+88% +$10.2M 0.18% 118
2023
Q4
$11.7M Buy
+467,655
New +$11.2M 0.11% 190

Other funds holding IBDX

NewEdge Advisors's IBDX Position: Q2 2026 in Review

NewEdge Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 5.6% in Q2 2026, buying an estimated $1.18M and bringing the position to 876,466 shares worth $22.1M. The position accounts for 0.07% of the portfolio, ranked #269.

NewEdge Advisors first reported a position in IBDX in Q4 2023 and has held it in 11 quarters since. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • NewEdge Advisors held 876,466 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $22.1M as of Q2 2026.
  • NewEdge Advisors bought 46,804 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.18M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.07% of NewEdge Advisors's portfolio in Q2 2026, its #269 holding.
  • NewEdge Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.